MacroGenics
MGNX
53 hedge funds and large institutions have $287M invested in MacroGenics in 2013 Q4 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
+$57.8M |
| 2 |
MAM
MPM Asset Management
Boston,
Massachusetts
|
+$46.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$31.4M |
| 4 |
BRC
Blue Ridge Capital
New York
|
+$23.5M |
| 5 |
PA
Perceptive Advisors
New York
|
+$18.8M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Barclays
London,
United Kingdom
| $2K | +$2.38K | +91 | New |
|
52
BNP Paribas Financial Markets
Paris,
France
| $1.92K | +$1.83K | +70 | New |
|
53
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $23 | +$22.3K | +851 | New |
|
MGNX Hedge Fund Activity: Q4 2013 in Review
53 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q4 2013, worth a combined $287M.
Buyers outnumbered sellers: 53 funds opened new MGNX positions and 0 closed out — a net gain of 53 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was TPG Group Holdings (SBS) Advisors, opening a new position worth an estimated $57.8M.
- 53 institutional investors held MacroGenics (MGNX) as of Q4 2013, up from 0 in Q3 2013.
- Funds reported $287M of MacroGenics stock for Q4 2013.
- 53 funds opened new MacroGenics positions in Q4 2013 and 0 closed out, a net change of +53 holders.
- The largest MacroGenics buyer in Q4 2013 was TPG Group Holdings (SBS) Advisors, an estimated $57.8M added.
Based on aggregated 13F filings for Q4 2013.